SANOFI PASTEUR has a total of 567 patent applications. It increased the IP activity by 800.0%. Its first patent ever was published in 1992. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are NMK RES LLC, SHANGHAI SUNWAY BIOTECH CO LTD and SOLVAY BIOLOGICALS BV.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 86 | |
#2 | WIPO (World Intellectual Property Organization) | 65 | |
#3 | Canada | 41 | |
#4 | Australia | 37 | |
#5 | United States | 37 | |
#6 | Republic of Korea | 33 | |
#7 | Brazil | 31 | |
#8 | Mexico | 28 | |
#9 | China | 27 | |
#10 | Israel | 27 | |
#11 | Argentina | 26 | |
#12 | South Africa | 21 | |
#13 | France | 12 | |
#14 | Singapore | 12 | |
#15 | Taiwan | 11 | |
#16 | New Zealand | 9 | |
#17 | Hong Kong | 8 | |
#18 | Peru | 6 | |
#19 | Philippines | 6 | |
#20 | Norway | 5 | |
#21 | African Regional Industrial Property Organization | 4 | |
#22 | Malaysia | 4 | |
#23 | Costa Rica | 3 | |
#24 | EAPO (Eurasian Patent Organization) | 3 | |
#25 | Georgia | 3 | |
#26 | Hungary | 3 | |
#27 | Serbia | 3 | |
#28 | Japan | 2 | |
#29 | Latvia | 2 | |
#30 | Morocco | 2 | |
#31 | Slovenia | 2 | |
#32 | Colombia | 1 | |
#33 | Germany | 1 | |
#34 | Guatemala | 1 | |
#35 | Lithuania | 1 | |
#36 | Luxembourg | 1 | |
#37 | Montenegro | 1 | |
#38 | Tunisia | 1 | |
#39 | Ukraine | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Packaging and shipping | |
#5 | Medical technology | |
#6 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Climate change adaptation technologies | |
#5 | Peptides | |
#6 | Fermentation | |
#7 | Containers for goods storage | |
#8 | Packaging | |
#9 | Medical purpose containers | |
#10 | Nanostructure applications |
# | Name | Total Patents |
---|---|---|
#1 | Guy Bruno | 77 |
#2 | Lang Jean | 72 |
#3 | Haensler Jean | 61 |
#4 | Barban Veronique | 56 |
#5 | Francon Alain | 48 |
#6 | Rokbi Bachra | 48 |
#7 | Forrat Remi | 44 |
#8 | Legastelois Isabelle | 37 |
#9 | Chacornac Isabelle | 37 |
#10 | Mistretta Noelle | 35 |
Publication | Filing date | Title |
---|---|---|
AU2019309173A1 | Ready-to-sell packaging unit containing at least one pharmaceutical product, set including a plurality of such packaging units and method for producing such packaging unit | |
EP3748639A1 | Method for determining at a current time point a preservation state of one product and computer system for carrying out said method | |
SG11202002933TA | Compositions for booster vaccination against dengu | |
US2020276301A1 | Human Cytomegalovirus Immunogenic Composition | |
EP3549603A1 | Live-attenuated yellow fever virus strain adapted to grow on vero cells and vaccine composition comprising the same | |
WO2018060771A1 | Live attenuated chimeric zika virus and its use as an immunogenic composition | |
CA3000591A1 | Immunogenic compositions against s. aureus | |
US2018193447A1 | Concomitant dengue and yellow fever vaccination | |
WO2017005654A1 | Concomitant dengue, diphtheria, tetanus, whooping cough (pertussis), polio, and haemophilus influenzae type b vaccination. | |
WO2017137085A1 | Meningitidis vaccines comprising subtilinases | |
AU2015366212A1 | Multimerization of recombinant protein by fusion to a sequence from lamprey | |
US2018125961A1 | Neisseria meningitidis trypsin-like serine protease polypeptides and compositions thereof | |
WO2016091890A2 | Meningitidis vaccines comprising subtilinases | |
US2018125959A1 | Compositions comprising N. meningitidis proteins | |
TW201620546A | Vaccine compositions | |
WO2016012385A1 | Vaccine composition comprising ipv and cyclodextrins | |
US2014178478A1 | Immuno-Adjuvant Emulsion | |
WO2014083194A1 | Methods for inducing antibodies | |
WO2014053246A1 | Vaccination against japanese encephalitis, measles, mumps and rubella | |
SG11201500508XA | Production of infectious influenza viruses |